We determined that expression of the IRE1α/XBP1s pathway was lower in pediatric cholestatic liver samples than in autoimmune hepatitis disease-control livers, indicating that these changes are likely due to the cholestatic liver diseases, rather than cirrhosis. The gene discussed is ERN1; the disease is medical procedure.